Sign In

CPG Infobase: Clinical Practice Guidelines

0 comment(s)

Record Id:
14645
Title:
Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders
Fulltext:
View PDF
Author
Katzman MA, Bleau P, Blier P, Chokka P, Kjernisted K, Van Ameringen M, et al
Publication/Review date:
2014-July 
Producers:
Anxiety Disorders Association of Canada
Fund Source:
Pfizer Canada
Purdue Canada
Valeant Canada
Janssen Inc.
Servier Canada
Shire Canada
Astra Zeneca Canada
Lundbeck Canada
Eli Lilly Canada

Bibliographic Source

Journal Citation:
BMC Psychiatry 2014;14(Suppl 1):S1-83.
Pages/Size:
83  Page(s)
References:
1448

Subject Information

Specialties:
Clinical pharmacology, Psychiatry,
Conditions:
Generalized Anxiety Disorder; Social Anxiety Disorder; Obsessive-Compulsive Disorder; Post-Traumatic Stress Disorders; Panic Disorder; Anxiety Disorders;
Domains:
Treatment, Diagnosis
Target Populations:
Child, Elderly, Adolescent, Adult, Pregnant or Nursing Mother
Target Gender:
Unknown
MeSH:
epidemiology ; Drug Therapy; Panic Disorder; Drug Therapy, Combination; Agoraphobia; Stress Disorders, Post-Traumatic; Phobic Disorders; Obsessive-Compulsive Disorder;

Copyright:

The copyright of this guideline and its companion documents belongs to: Martin A Katzman et al

Disclaimer:
All content is provided for information and education and not as a substitute for the advice of a physician. Joule assumes no responsibility or liability arising from any error or omission or from the use of any information contained herein.

Discuss this CPG

Share your ideas and expertise on this topic.

​​​